The novelty of this review lies in its targeted examination of clinical outcomes specifically among Lynch syndrome patients under the age of 60, emphasizing how different mutation patterns in the MMR genes influence prognosis, survival, and treatment decisions. Here, MRC1 is linked to Lynch syndrome.